Investor profile
Good Growth Capital
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Good Growth Capital is a majority women- and minority-managed early-stage venture capital firm that invests in transformative science and technology companies addressing pressing societal needs. The firm focuses on four core verticals — Life Sciences (medical devices, therapeutics, diagnostics), Data Sciences (AI/ML, NLP, SaaS, big data), GreenTech (clean energy, battery tech, advanced materials, hard sciences), and Consumer — deploying pre-seed through Series B capital. All investments are aligned with ESG and UN Sustainable Development Goals, and the firm targets top-decile financial returns while making a measurable positive impact on the world.
Notable quotes
“Now having over $100 million to deploy allows us to put more money to work in businesses that will make a positive impact on the world. We could not be more excited about the future of Good Growth and our current and future portfolio companies.”
“Good Growth is grateful for Triago believing in our team early on. Triago worked hard to make this a successful fundraise and introduce us to many established institutional investors who were increasing their allocation to impact investing – including ESG, diverse founders and impact industries such as healthtech and greentech.”
“GGC was one of our earliest believers and provided guidance and valuable references to other investors as we prepared for our seed round. GGC's continued involvement is a testament to their commitment. It's a pleasure to work with talented women investors who bring both their scientific and tech expertise, and business perspective.”
Team
Aditi Rajagopal
Principal
Amy Salzhauer
Founder & Managing Partner
Carolyne LaSala
Managing Partner
David Mendez
Managing Partner
Maureen Stancik Boyce
Founder & Managing Partner
Sophie Hagerty
Principal
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Osteoboost Health | Series A Extension | — | 2026-04 |
| Ateios Systems | Series A | — | 2026-03 |
| Avisi Technologies | Series A | — | 2026-02 |
| Dalan Animal Health | Seed | — | 2025-11 |
| Coral Innovations | Seed | — | 2025-08 |
| Pryon | Series A | $20m | 2019 |
| Skyhawk Therapeutics | Seed | — | 2017 |
| OrbitFab | Seed | — | 2020 |
| Tevard Biosciences | Series A | — | 2022 |
| Form Energy | Seed | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Gaingels | 5 |
| Greycroft | 2 |
| Breyer Capital | 2 |
| Revolution Rise of the Rest | 2 |
| Climate Capital | 1 |
| Techstars | 1 |
Fit check
Is Good Growth Capital a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit